Objective: We aimed to determine the correlation of cardiovascular risk parameters with serum interleukin-6 (IL-6) and highsensitivity C-reactive protein (hs-CRP) in patients with acute myocardial infarction (AMI). Methods: This cross-sectional study was conducted among patients admitted to the intensive care unit (ICCU) King Abdulaziz University Hospital, Jeddah, from March 2019-February, 2020. Blood samples and other data were collected from 100 adult AMI patients admitted to the ICCU (age, 40-60 years) and from 40 age-and BMI-matched healthy adults. Results: The comparison of median and interquartile range of the IL-6 and hs-CRP levels showed that the median values in the MI group were significantly higher than in the healthy control (p < 0.001). Levels of FPG, HbA1c, TG, LDLc were significantly higher, while HDLc was significantly lower in MI patients than control subjects. In the MI group, hs-CRP showed a significant correlation with BMI (r=0.531; p<0.001), and waist circumference (r=0.448; p<0.001). With regard to the gender-based comparison, the hs-CRP and IL-6 levels were not significantly different in male and female MI patients (5.90±2.0 vs. 6.80±8.2; p=0.166 and 21.23±8.2 vs. 21.06 ±8.7; p=0.948, respectively). However, IL6 levels were significantly different between males and females in the control groups (6.64±3.0 vs. 9.74±4.7;p=0.017). Conclusion: IL-6 and hs-CRP were significantly higher in MI than the healthy group. No correlation was found with biochemical parameters. Further research is needed to explore the pathways involving these two molecules in the pathogenesis of MI.
Objective: The aim of this study is to determine the prevalence of cardiovascular disease with micro albuminuria in type 2 diabetes mellitus. Study Design: Observational study Place and Duration: Study was carried out in medicine department of DHQ category A hospital Batkhela and Combined Military Hospital, Multan for duration of six months from January 2020 to June 2020. Methods: Total 120 patients of both genders diagnosed diabetes 2 mellitus were presented in this study. Patients were aged between 20-80 years. Patients’ details demographics were recorded after taking written consent. Prevalence of cardiovascular disease with microalbuminuria was assessed by statistical analysis. Microalbuminuria was diagnosed among patients if urinary albumin excretion was >30mg/g and in normal albuminuria urinary albumin excretion was <30mg/g. Complete data was analyzed by SPSS 20.0 version. Results: Out of 120, 66 (55%) were males and 54 (45%) were females. Mean age of the patients were 45.71±16.9 years with mean BMI 26.14±9.22 kg/m2. Cardiovascular disease found in 90 (75%) cases. We found that 80 (66.7%) patients had microalbuminuria with mean ACR 160.4±74.6 mg/gm while rest of the patients 40 (33.3%) had normal albuminuria 19.14±5.4 mg/gm. Among 90 cases of cardiovascular disease frequency of microalbuminuria was 65 (72.22%) and among 30 diabetes patients of non- cardiovascular disease frequency of microalbuminuria were 15 (50%). Microalbuminuria was found significantly higher in patients of cardio vascular disease and increased systolic and diastolic blood pressure compared to normoalbuminuric patients. In patients with microalbuminuria, blood glucose and glycosylated hemoglobin have increased dramatically. Conclusion: We concluded in this study that the prevalence of cardiovascular disease with micro albuminuria in type 2 diabetes mellitus was significantly high <0.05 with increased systolic diastolic pressure and fasting blood glucose as compared to normal albuminuria. Keywords: Microalbuminuria, Normal albuminuria, Type 2 Diabetes, Cardio vascular disease
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.